Skip to main content
. 2023 Sep 4;4(5):e353. doi: 10.1002/mco2.353

FIGURE 1.

FIGURE 1

Grouping of medicines recommended for use in longer multidrug‐resistant TB (MDR‐TB) regimens by the WHO. 2 Group A drugs are strongly recommended for inclusion in all longer MDR‐TB regimens containing fluoroquinolones, bedaquiline, and linezolid. Group B drugs were recommended to add one or two to the regimen to improve outcomes. Group C drugs were recommended as a secondary option to Group A and B drugs.